Dr. Douglas Johnson discusses the potential toxicities that are associated with immunotherapy in melanoma patients.

Meredith McKean MD, MPH with Sarah Cannon Research Institute, Douglas Johnson, MD, Assistant Professor of Medicine at Vanderbilt, and Roman Groisberg, MD Medical Oncologist at Rutgers Health joined GRACE to discuss current updates in treatment for Melanoma.

A huge thank you to our sponsors #Merck and #Exelixis!

For more, please visit http://cancerGRACE.org/. To join the conversation, visit https://cancergrace.org/forum.